Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Takeyama

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1989
[Interstitial pneumonia (IP) in bone marrow transplantation in leukemia--120 cases analysis in Nagoya Bone Marrow Transplantation Group]H Yamada, H Takeyama, A Abe, et al.
Clinical and Experimental Immunology|March 1, 1978
Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapyK Kawashima, Y Morishima, Y Kato, et al.
Surgery Today|November 7, 1999
An extremely large solitary primary paraganglioma of the lung: report of a caseT Saeki, T Akiba, K Joh, et al.
International Journal of Cancer|May 15, 1983
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cellsP O Livingston, H Takeyama, M S Pollack, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 1999
[An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma]Y Akamo, H Takeyama, N Mohri, et al.
The Journal of Experimental Medicine|December 1, 1982
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2T Watanabe, C S Pukel, H Takeyama, et al.
European Journal of Clinical Investigation|April 9, 2005
Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12S Homma, T Kikuchi, N Ishiji, et al.
Japanese Journal of Cancer Research : Gann|June 8, 1999
Posttreatment M-protein nadir level is a significant prognostic factor associated with survival in multiple myeloma. Nagoya Myeloma Cooperative Study GroupK Shimizu, O Kamiya, N Hirabayashi, et al.
Kekkaku : [Tuberculosis]|February 24, 1999
[Clinical analysis of foreign patients with tuberculosis found in Chugoku-Shikoku area]Y Kobashi, T Matsushima, S Kawahara, et al.
British Journal of Cancer|July 1, 2015
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cellsT Higashi, H Hayashi, T Ishimoto, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1989
[Interstitial pneumonia (IP) in bone marrow transplantation in leukemia--120 cases analysis in Nagoya Bone Marrow Transplantation Group]H Yamada, H Takeyama, A Abe, et al.
Clinical and Experimental Immunology|March 1, 1978
Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapyK Kawashima, Y Morishima, Y Kato, et al.
Surgery Today|November 7, 1999
An extremely large solitary primary paraganglioma of the lung: report of a caseT Saeki, T Akiba, K Joh, et al.
International Journal of Cancer|May 15, 1983
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cellsP O Livingston, H Takeyama, M S Pollack, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 1999
[An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma]Y Akamo, H Takeyama, N Mohri, et al.
The Journal of Experimental Medicine|December 1, 1982
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2T Watanabe, C S Pukel, H Takeyama, et al.
European Journal of Clinical Investigation|April 9, 2005
Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12S Homma, T Kikuchi, N Ishiji, et al.
Japanese Journal of Cancer Research : Gann|June 8, 1999
Posttreatment M-protein nadir level is a significant prognostic factor associated with survival in multiple myeloma. Nagoya Myeloma Cooperative Study GroupK Shimizu, O Kamiya, N Hirabayashi, et al.
Kekkaku : [Tuberculosis]|February 24, 1999
[Clinical analysis of foreign patients with tuberculosis found in Chugoku-Shikoku area]Y Kobashi, T Matsushima, S Kawahara, et al.
British Journal of Cancer|July 1, 2015
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cellsT Higashi, H Hayashi, T Ishimoto, et al.
Pageof 13